GlaxoSmithkline Pharmaceuticals Limited at its Board of Directors held on May 19, 2017, the Board has recommended a dividend of 300% on the equity share capital of INR 30 per equity share for the year ended March 31, 2017. The dividend if approved by the shareholders will be paid after July 25, 2017.